This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03900429
Brief Title: A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis (MAESTRO-NASH)

First Submitted : March 26, 2019
First Submitted that Met QC Criteria : March 30, 2019
First Posted : April 3, 2019

Certification/Extension First Submitted : November 30, 2023
Certification/Extension First Posted : February 20, 2024

Last Update Submitted that Met QC Criteria : February 15, 2024
Last Update Posted : February 20, 2024